Takeover

Acquirers

Revolution Medicines, Inc.

Targets
2
Filings
2
Median premium
94%
First filing
Sep 29, 2023
Latest filing
Sep 29, 2023

Targets

CompanyScore before dealScore nowFilingsLatest
EQRx, Inc.——1Sep 29, 2023
RVMDRevolution Medicines, Inc.2 / 73 / 131Sep 29, 2023

Deal filings

FiledCompanyFormPricePremium
Sep 29, 2023EQRx, Inc.DEFM14A$32.1130%
Sep 29, 2023RVMDRevolution Medicines, Inc.DEFM14A$32.1194%